TIERRA IZZARD-JEFFERY: Open Payments
NPI 1386333714 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 8 payments from 7 companies in 2025. Trend: 2023 $18 · 2024 $35 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Neos Therapeutics, LP | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: REXULTI, CAPLYTA, Adzenys XR-ODT, HETLIOZ, Auvelity, VRAYLAR.
Industry payments across SC — which companies pay providers there.
